Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × nintedanib × Clear all

NCT01610869 2019-05-29

METRO-BIBF

Phase 2 Completed

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Recurrence

NCT01669798 2018-10-16

BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer

Phase 2 Completed

32 enrolled 19 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00710762 2016-08-15

A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer

Phase 2 Completed

89 enrolled 10 charts

Ovarian Neoplasms